###begin article-title 0
Hyaluronan- and RNA-binding deubiquitinating enzymes of USP17 family members associated with cell viability
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
Protein degradation by the ubiquitin system plays a crucial role in numerous cellular signaling pathways. Deubiquitination, a reversal of ubiquitination, has been recognized as an important regulatory step in the ubiquitin-dependent degradation pathway.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 122 128 122 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17 </italic>
###xml 289 295 289 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17 </italic>
###xml 112 118 <span type="species:ncbi:9606">humans</span>
###xml 234 239 <span type="species:ncbi:9606">human</span>
###xml 402 407 <span type="species:ncbi:9606">human</span>
While identifying putative ubiquitin specific protease (USP) enzymes that contain a conserved Asp (I) domain in humans, 4 USP17 subfamily members, highly homologous to DUB-3, have been found (USP17K, USP17L, USP17M, and USP17N), from human chorionic villi. Expression analysis showed that USP17 transcripts are highly expressed in the heart, liver, and pancreas and are expressed moderately in various human cancerous cell lines. Amino acid sequence analysis revealed that they contain the highly conserved Cys, His, and Asp domains which are responsible for the deubiquitinating activity. Biochemical enzyme assays indicated that they have deubiquitinating activity. Interestingly, the sequence analysis showed that these proteins, with exception of USP17N, contain the putative hyaluronan/RNA binding motifs, and cetylpyridinium chloride (CPC)-precipitation analysis confirmed the association between these proteins and intracellular hyaluronan and RNA.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
Here, we report that the overexpression of these proteins, with exception of USP17N, leads to apoptosis, suggesting that the hyaluronan and RNA binding motifs in these enzymes play an important role in regulating signal transduction involved in cell death.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 284 285 284 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 286 287 286 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 594 595 594 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 697 698 697 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 699 700 699 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 701 702 701 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 1170 1171 1170 1171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 1172 1174 1172 1174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1301 1302 1301 1302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 1419 1420 1419 1420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 1632 1634 1632 1634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1769 1771 1769 1771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1906 1907 1906 1907 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 587 592 <span type="species:ncbi:4932">yeast</span>
The post-translational modification by ubiquitin (Ub) plays an essential role for numerous cellular functions such as protein degradation, cell cycle control, transcriptional regulation, immune response, apoptosis, oncogenesis, pre-implantation, and intracellular signaling pathways [1-6]. Conjugation of ubiquitin to a target protein is achieved by the sequential enzymatic actions via ubiquitin-activating enzymes (E1), ubiquitin-conjugating enzymes (E2), and ubiquitin ligases (E3). A novel ubiquitination factor (E4) required for efficient multiubiquitination has been identified in yeast [7]. Proteins modified with a polyubiquitin chain are then unfolded and degraded by the 26S proteasome [1,4,5]. Deubiquitination, a removal of ubiquitin from ubiquitin-conjugated protein substrates, is mediated by a number of deubiquitinating enzymes. Most deubiquitinating (DUB) enzymes are cysteine proteases and consist of at least five families, the ubiquitin C-terminal hydrolases (UCH), the ubiquitin specific processing proteases (USP), Jab1/Pab1/MPN-domain-containing metallo-enzymes (JAMM), Otu-domain ubiquitin aldehyde-binding proteins (OTU), and Ataxin-3/Josephin [8-10]. The USP family members vary in size and structural complexity, but all contain 6 characteristic conserved homology domains [5]. The UCH family members are relatively small molecules, which hydrolyze C-terminal amides and esters of ubiquitin [5]. The JAMM isopeptidases are known to deneddylate cullin (the CSN-5 subunit of the COP9/signalosome) and to release ubiquitin chains from proteins targeted for degradation (the RPN11 subunit of the proteasome) [11]. The members of OTU family have been reported as highly specific Ub isopeptidases, but they have no sequence homology to known DUBs [12]. Lastly, Ataxin-3 has a domain called the Josephin domain, cleaves ubiquitin-AMC, and binds to the DUB inhibitor ubiquitin aldehyde [8].
###end p 9
###begin p 10
###xml 97 99 97 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 116 118 116 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 119 121 119 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 143 145 143 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 255 257 255 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 509 511 509 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 541 543 541 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
Hyaluronan is a kind of glycosaminoglycan, which is involved in the regulation of cell division [13], angiogenesis [14,15], and cell motility [16]. Hyaluronan exists in extracellular and pericellular matrices and interacts with various kinds of proteins [17]. Recent reports showed the existence of a few intracellular hyaluronan binding proteins (IHABPs) and one of them, receptor form hyaluronan-mediated motility (RHAMM) binds intracellular hyaluronan and plays multiple roles including cell cycle arrest [18] and spindle pole stability [19].
###end p 10
###begin p 11
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17 </italic>
###xml 57 59 57 59 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 78 83 78 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DUB-3</italic>
###xml 131 137 131 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DUB-3 </italic>
###xml 185 187 185 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 246 252 246 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17 </italic>
###xml 307 312 <span type="species:ncbi:9606">human</span>
USP17 subfamily members have been previously identified [20] and one of them, DUB-3, has shown that the constitutive expression of DUB-3 blocks proliferation and can lead to apoptosis [21]. In this study, we have identified four novel members of USP17 subfamily which encode a deubiquitinating enzyme, from human chorionic villi tissues. Our study demonstrates for the first time that USP17 subfamily members of the DUB enzyme regulate apoptosis and cell death of cancerous cells and contain putative hyaluronan and RNA binding domains.
###end p 11
###begin title 12
Results
###end title 12
###begin title 13
###xml 11 17 11 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17 </italic>
###xml 38 43 <span type="species:ncbi:9606">human</span>
Cloning of USP17 subfamily members in human chorionic villi and embryonic carcinoma cell lines
###end title 13
###begin p 14
###xml 208 210 208 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 265 271 265 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DUB-3 </italic>
###xml 272 274 272 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 280 286 280 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17 </italic>
###xml 287 289 287 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 516 522 516 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17 </italic>
###xml 541 547 541 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17K</italic>
###xml 549 555 549 555 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17L</italic>
###xml 557 563 557 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17M</italic>
###xml 569 575 569 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17N</italic>
###xml 622 624 622 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 625 627 625 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 678 684 678 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17 </italic>
###xml 728 734 728 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17K</italic>
###xml 736 742 736 742 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17L</italic>
###xml 744 750 744 750 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17M</italic>
###xml 756 763 756 763 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17N </italic>
###xml 1025 1031 1025 1031 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17K</italic>
###xml 1033 1040 1033 1040 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17L </italic>
###xml 1044 1051 1044 1051 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17M </italic>
###xml 1200 1217 1200 1217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">Additional File 1</xref>
###xml 1245 1252 1245 1252 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17N </italic>
###xml 1406 1423 1406 1423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">Additional File 1</xref>
###xml 1603 1604 1603 1604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 1709 1711 1709 1711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 1721 1723 1721 1723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 1737 1739 1737 1739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 1985 1986 1985 1986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 2136 2142 2136 2142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17 </italic>
###xml 2158 2159 2158 2159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 89 95 <span type="species:ncbi:9606">humans</span>
###xml 296 301 <span type="species:ncbi:9606">human</span>
###xml 672 677 <span type="species:ncbi:9606">human</span>
To identify putative deubiquitinating enzymes that contain a conserved Asp (I) domain in humans, the GenBank database was accessed and searched using the BLAST algorithm at the NCBI, as described previously [22]. In this study, we obtained multiple cDNAs including DUB-3 [21] and USP17 [23] from human chorionic villi tissues and various cancer cell lines by RT-PCR. We performed RT-PCR, sequenced PCR products three times independently in order to exclude the possibility of PCR errors, and classified the genes as USP17 subfamily members (USP17K, USP17L, USP17M, and USP17N) due to the high homology to known sequences [20,21]. To characterize the genetic properties of human USP17 genes, the complete nucleotide sequences of USP17K, USP17L, USP17M, and USP17N [GenBank: , , , and , respectively] were analyzed. Nucleotide and deduced amino acid sequences were analyzed with the SeqEd V1.0.3 program and Clustal method of the MegAlign program, a multiple alignment program of the DNASTAR package. The full-length cDNAs for USP17K, USP17L and USP17M consist of 1593 nucleotides in open reading frame and the deduced amino acid sequence of 530 amino acids with a calculated molecular mass of 58 kDa (Additional File 1). The full-length cDNA for USP17N consists of 1197 nucleotides in open reading frame and the deduced amino acid sequence of 398 amino acids with a calculated molecular weight of 44.5 kDa (Additional File 1). The conserved Cys, His and Asp domains, which are thought to form the active site of the deubiquitinating enzymes, are also found in the USP17K, USP17L, USP17M and USP17N (Fig. 1); these conserved domains have been previously shown in other deubiquitinating enzymes including USP36 [24], DUB-1 [25], and DUB-2 [26]. Sequence analysis for amino acids of novel USP17 subfamily members indicates that USP17K, USP17L and USP17M have high degree of homology (>95%), and USP17N is identical with USP17C when compared with each other and USP17 family members (Table 1). Phylogenetic analysis for nucleotide sequences and deduced amino acid sequences of novel genes revealed that all novel genes were grouped into the USP17 subfamily (Fig. 2) and they were characterized in this report.
###end p 14
###begin p 15
###xml 73 75 73 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 187 188 187 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 197 198 197 198 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 206 208 206 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 322 323 322 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 495 496 495 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 760 762 760 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 595 600 <span type="species:ncbi:9606">human</span>
###xml 643 649 <span type="species:ncbi:10090">murine</span>
###xml 827 833 <span type="species:ncbi:10090">murine</span>
Examination of the deduced amino acid sequence of these enzymes by Pfam [27] revealed that novel subfamily members of USP17 contain the putative conserved hyaluronan binding motifs (Fig. 3) -(R/K)X7(R/K)- [28]. These putative motifs are located between amino acid residues Arg 401 to Lys 410, and Lys 445 to Lys 453 (Fig. 3). In addition, "RGG" amino acid sequences predicted for the novel RNA binding motif are found at the C-terminus. Interestingly, USP17N lacks of these binding motifs (Fig. 3), suggesting the unique functional roles for these motifs. Even though it has been suggested that human USP17 subfamily members are homologous to murine DUB subfamily members due to the fact that they are cytokine-inducible and regulate cell growth and survival [20], hyaluronan and RNA binding motifs are not found in members of murine DUB subfamily (data not shown).
###end p 15
###begin title 16
###xml 36 42 36 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17 </italic>
###xml 63 68 <span type="species:ncbi:9606">human</span>
Expression of transcripts for novel USP17 subfamily members in human tissues and cancerous cells
###end title 16
###begin p 17
###xml 63 69 63 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17 </italic>
###xml 194 196 194 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 257 263 257 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17 </italic>
###xml 470 477 470 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17L </italic>
###xml 543 549 543 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17 </italic>
###xml 613 620 613 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17L </italic>
###xml 642 644 642 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 754 760 754 760 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DUB-3 </italic>
###xml 767 769 767 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 943 949 943 949 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17 </italic>
###xml 1133 1139 1133 1139 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17 </italic>
###xml 1265 1267 1265 1267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 90 95 <span type="species:ncbi:9606">human</span>
###xml 1050 1055 <span type="species:ncbi:9606">human</span>
###xml 1181 1186 <span type="species:ncbi:9606">human</span>
To investigate the expression pattern of transcripts for novel USP17 subfamily members in human tissues and cancerous cells, Northern blot and RT-PCR analyses were performed. As shown in Figure 4A, Northern blot analysis revealed that transcripts for novel USP17 subfamily members were expressed in the heart, liver, and pancreas at a high level. Interestingly, we obtained multiple bands having different sizes (1.7 kb, 1.6 kb, 1.3 kb, 1 kb) using a 5' 500 bp probe of USP17L (Probe: N-500). We also detected 1.6 kb and 1.7 kb major bands of USP17 subfamily members using a probe designed for a 3' 1 kb probe of USP17L (Probe: C-1000) (Fig. 4A). It is possible that other minor mRNA transcripts around 1.3 kb and 1 kb, which have not been detected with DUB-3 probe [21], may be derived from alternative splicing, promoter usage, or poly (A+) usage. The presence of a few different sizes of transcript indicates that novel genes belong to the USP17 subfamily and that there are at least several members of this family present. In addition to various human tissues, RT-PCR analysis showed that the expression of transcripts for novel USP17 subfamily members was detected in various human cancer cell lines including HeLa, HEC-1A, NCCIT, and fibrosarcoma cells (Fig. 4B).
###end p 17
###begin title 18
Novel USP17 subfamily members as a deubiquitinating enzyme
###end title 18
###begin p 19
###xml 156 165 156 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 291 292 291 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 386 387 383 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 602 603 599 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 631 632 628 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
To determine whether novel USP17 subfamily proteins have ubiquitin specific protease enzymatic activity, deubiquitinating enzyme assays were performed. For in vitro enzyme assay, novel USP17 subfamily members were expressed as a GST fusion protein. As shown by immunoblotting analysis (Fig. 5), four GST fusion proteins demonstrated a strong efficient cleavage of Ub-Met-beta-gal (Fig. 5; lanes 2, 4, 6, and 8). We generated the Cys conserved domain mutant for each of novel USP17 subfamily proteins (C89S) using a site-directed mutagenesis method. As expected, cells with the empty vector alone (Fig. 5, lane 1) and mutants (Fig. 5; lanes 3, 5, 7 and 9) failed to cleave Ub-Met-beta-gal.
###end p 19
###begin p 20
###xml 4 12 4 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 169 176 169 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17L </italic>
###xml 191 198 191 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17L </italic>
###xml 416 423 416 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17L </italic>
###xml 429 430 429 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 480 487 480 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17L </italic>
###xml 500 501 500 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 777 785 777 785 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 99 104 <span type="species:ncbi:9606">human</span>
For in vivo deubiquitinating enzyme assay, HA-tagged pMT123-ubiquitin was transiently expressed in human endometrial carcinoma cells (HEC-1A) with or without pcDNA3-myc-USP17L and pcDNA3-myc-USP17L (C89S). Then, we analyzed deubiquitinating enzyme activity by immunoblotting using a monoclonal anti-HA antibody. The expression bands of polyubiquitinated proteins were nearly invisible in cells expressing pcDNA3-myc-USP17L (Fig. 6; lane 4), but not in cells expressing pcDNA3-myc-USP17L (C89S) (Fig. 6; lane 5). The molecular weight for a mutant form of USP17L (C89S) is bigger than wild type USP17L, suggesting that there may be a conformational change due to the amino acid substitution. In addition, other USP17 subfamily members showed the deubiquitinating enzyme activity in vivo (data not shown). Taken together, we concluded that novel USP17 subfamily proteins have deubiquitinating enzyme activity.
###end p 20
###begin title 21
Hyaluronan/RNA-binding properties of USP17 subfamily proteins
###end title 21
###begin p 22
###xml 295 297 295 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 490 492 490 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7A</xref>
###xml 565 567 565 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7A</xref>
Since it is not known whether hyaluronan-binding sites within USP17 subfamily proteins are indeed functional, we further examined whether USP17 subfamily proteins actually binds hyaluronan. The cetylpyridinium chloride (CPC)-precipitation assay has been used for investigating binding affinity [29] and the assay in our study demonstrated that USP17 subfamily proteins interact with hyaluronan based on the comparison of binding intensity between endogenous and exogenous hyaluronans (Fig. 7A, lanes 4 and 5). However, USP17N did not interact with hyaluronan (Fig. 7A, lane 5), indicating that the C-terminal domain of USP17 subfamily proteins is required for binding with hyaluronan.
###end p 22
###begin p 23
###xml 96 98 96 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 141 143 141 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 370 372 370 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7A</xref>
###xml 377 379 377 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7B</xref>
###xml 461 463 461 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7A</xref>
Since it has been reported that the HABP4_PAI-RBP1 domain, which is involved in mRNA stability [30], interacts with both hyaluronan and RNA [17], we additionally investigated the activity of USP17 subfamily proteins for binding with RNA. We performed the CPC-precipitation assay and found that USP17 subfamily proteins also bind to RNA in a dose-dependent manner (Figs. 7A and 7B). Interestingly, USP17N did not interact with RNA as shown with hyaluronan (Fig. 7A, lane 6), indicating that the C-terminal domain of USP17 subfamily proteins is also required for binding with RNA.
###end p 23
###begin title 24
Localization study of USP17L
###end title 24
###begin p 25
###xml 269 271 269 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8E</xref>
###xml 276 278 276 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8H</xref>
###xml 317 319 317 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 402 404 402 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8F</xref>
###xml 409 411 409 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8I</xref>
###xml 501 503 501 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8G</xref>
###xml 508 510 508 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8J</xref>
###xml 756 763 756 763 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17N </italic>
In order to investigate the intracellular localization of USP17 subfamily proteins, the GFP-tagged USP17L or RFP-tagged USP17N, or both were transfected into HeLa cells. Intriguingly, USP17L proteins are found in the nucleus and are concentrated at the nucleoli (Figs. 8E and 8H) similar to intracellular hyaluronan [31]. However, USP17N proteins are localized both in the nucleus and cytoplasm (Figs. 8F and 8I). A merged format shows that USP17L and USP17N are localized in different regions (Figs. 8G and 8J). After 48 hours of transfection, cells expressing GFP-tagged USP17L showed the onset of irregular nuclear division and irregular morphology of overall cell shape compared with controls (data not shown). In contrast, cells expressing RFP-tagged USP17N did not show any sign of apoptosis, suggesting that hyaluronan binding ability and the localization of USP17 subfamily proteins may be critical for regulating apoptosis leading to cell death.
###end p 25
###begin title 26
Regulation of cell viability
###end title 26
###begin p 27
###xml 108 110 108 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 111 113 111 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 339 346 339 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17L </italic>
###xml 487 488 487 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9</xref>
###xml 575 582 575 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17L </italic>
###xml 592 599 592 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17N </italic>
###xml 670 671 670 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9</xref>
###xml 851 857 851 857 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17L</italic>
###xml 1068 1074 1068 1074 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17L</italic>
###xml 1122 1124 1122 1124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10</xref>
###xml 1167 1174 1167 1174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17L </italic>
###xml 1206 1212 1206 1212 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17N</italic>
###xml 1268 1270 1268 1270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10</xref>
Since it has been suggested that intracellular hyaluronan binding proteins are involved in tumor formation [32,33], we next investigated whether the USP17 subfamily proteins are involved in the regulation of cell viability and cell cycle for cancer cells. In order to investigate the cellular roles of USP17 subfamily proteins, myc-tagged USP17L was transfected into HEC-1A and HeLa cells to establish stable cell lines. However, we observed transfected cells undergoing apoptosis (Fig. 9) and approximately 3 weeks later, all cells died. However, the transfection of either USP17L (C89S) or USP17N into the same cell lines did not result in any sign of apoptosis (Fig. 9). This indicates that USP17 subfamily proteins containing hyaluronan binding motifs and their substrate(s) may regulate cell viability. Based on the observation of cell death for USP17L-transfected cells, we performed quantitative real-time PCR to compare fold change for the expression of caspase 3 as an indicator of apoptosis. The expression of caspase 3 showed more than two fold increase in USP17L-transfected cells compared with controls (Fig. 10). However, the expression of caspase 3 in USP17L (C89S)-transfected cells and in USP17N-transfected cells was similar to one in controls (Fig. 10). All reactions were performed triplicate.
###end p 27
###begin p 28
###xml 71 78 71 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17L </italic>
###xml 222 229 222 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17L </italic>
###xml 275 281 275 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17L</italic>
###xml 417 424 417 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17L </italic>
###xml 427 434 427 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17L </italic>
###xml 499 501 499 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F11">11</xref>
###xml 665 667 665 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 674 680 674 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17L</italic>
###xml 899 901 899 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F11">11</xref>
###xml 973 980 973 980 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17L </italic>
###xml 988 995 988 995 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17N </italic>
###xml 1001 1003 1001 1003 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F11">11</xref>
In order to confirm the apoptosis induced by USP17 subfamily proteins, USP17L was stably expressed by the Tet-on system. The morphology of cells undergoing apoptosis was similar to that of ones transfected with pcDNA3-myc-USP17L (data not shown). Therefore, we harvested the USP17L-expressing cells at 1 week intervals for 3 weeks and analyzed through FACS analysis. The rate of apoptosis for cells expressing either USP17L or USP17L (CS) was analyzed by double-staining with annexin V and PI (Fig. 11). The cell stages of apoptosis were differentiated depending on the location in the quadrant (annexin V +, PI -; early stage) and (annexin V +, PI +; late stage) [34]. The USP17L-expressing cells by the Tet-on system undergoing the early stage apoptosis showed about 2.5 fold increase compared with control HeLa cells and those undergoing late stage apoptosis showed about 1.5 fold increase (Fig. 11). However, the significant change was not observed in cells expressing USP17L (CS) or USP17N (Fig. 11). This experiment was performed triplicate.
###end p 28
###begin title 29
Discussion
###end title 29
###begin p 30
###xml 378 384 378 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17 </italic>
###xml 504 510 504 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17 </italic>
###xml 511 528 511 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">Additional File 1</xref>
###xml 614 620 614 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17 </italic>
###xml 690 696 690 696 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17 </italic>
###xml 712 713 712 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 802 808 802 808 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17 </italic>
###xml 836 841 836 841 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DUB-3</italic>
###xml 897 899 897 899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 928 932 928 932 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DUB </italic>
###xml 960 965 960 965 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DUB-1</italic>
###xml 967 972 967 972 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DUB-2</italic>
###xml 974 980 974 980 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DUB-2A</italic>
###xml 986 993 986 993 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DUB-1A </italic>
###xml 994 995 994 995 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 996 997 996 997 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 998 1000 998 1000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 1001 1003 1001 1003 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 921 927 <span type="species:ncbi:10090">murine</span>
The ubiquitin-mediated protein degradation pathway has diverse functions involved in the regulation of protein activity, indicating the importance of the system in eukaryotic cells. Specific modulation by diverse deubiquitinating enzyme is a key process controlling many proteins associated with the ubiquitin-proteasome system. In this study, we isolated four novel members of USP17 subfamily and showed through sequence analysis that they have high degree of homology when compared with each other and USP17 (Additional File 1). Phylogenetic analysis for nucleotide sequences and deduced amino acid sequences of USP17 subfamily members revealed that all novel genes were grouped into the USP17 subfamily (Fig. 1). It has been recently reported that there are multiple homologous genomic sequences of USP17 subfamily, and one of them, DUB-3, encodes a cytokine-inducible deubiquitinating enzyme [21]. This is similar to murine DUB subfamily members including DUB-1, DUB-2, DUB-2A, and DUB-1A [1,9,25,26]. However, whether they have distinct functions or polymorphisms remains to be seen.
###end p 30
###begin p 31
###xml 6 12 6 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17 </italic>
###xml 216 218 216 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 636 639 636 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F11">11A</xref>
###xml 644 647 644 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F11">11B</xref>
Since USP17 transcripts were expressed in various cancer cell lines and it has been suggested that intracellular hyaluronan binding proteins, which USP17 subfamily members belong to, are involved in tumor formation [33], we investigated whether USP17 subfamily proteins are involved in cell growth and proliferation. Interestingly, we observed that cancer cells (HeLa and HEC-1A) overexpressing USP17 subfamily proteins except USP17N appeared morphologically abnormal. In addition, FACS analysis showed that double-staining of USP17L-expressing, but not USP17N-expressing cells with annexin V and PI revealed increased apoptosis (Figs. 11A and 11B). These results suggest that USP17 subfamily proteins containing hyaluronan and RNA binding motifs are involved in signaling pathway of death for tumorigenic cells.
###end p 31
###begin p 32
###xml 364 366 364 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 367 369 367 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 433 435 433 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 436 438 436 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 656 658 656 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 659 661 659 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 844 846 844 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 1561 1563 1561 1563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 1564 1566 1564 1566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 1590 1598 1590 1598 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 1733 1734 1733 1734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
Besides the fact that the overexpression of USP17 subfamily proteins induces apoptosis in cancer cells, the ability to bind with hyaluronan is another important point used to elucidate the cellular functions of USP17 subfamily proteins. Hyaluronan is one of glycosaminoglycans and is believed to play various roles both in extracellular and pericellular matrices [32,35]. Since enriched hyaluronan is found in various tumor tissues [32,33], it was thought to be important for cancer. Several evidences have been proposed to prove the connection between hyaluronan and tumor growth. Therefore, hyaluronan is used as a marker for various cancers these days [32,33]. In addition, hyaluronan has been suggested that it is involved in the fundamental regulation of cell cycle, because hyaluronan is enriched in the nucleus during the cell division [31]. Since USP17 subfamily proteins except USP17N binds to hyaluronan and induces cell death, it is possible that hyaluronan and/or RNA binding domains of USP17 subfamily proteins may be involved in the regulation of cell cycle or tumorigenesis. Another possibility is that hyaluronan may serve as a bridge between the USP17 subfamily enzymes and their potential substrates, which are intracellular hyaluronan-binding proteins. Moreover, USP17 subfamily proteins are condensed at the nucleoli like hyaluronan dose, suggesting that USP17 subfamily proteins are involved in mRNA stability or chromatin remodeling similar to functions of PAI-RBP1 and Ki-1/57, which are hyaluronan/RNA binding motif-containing proteins [29,30]. Due to the fact that in vivo deubiquitinating enzyme assay for USP17 subfamily members showed the extensive reduction of ubiquitination for cellular proteins (Fig. 6), it is possible that a number of proteins including apoptosis-related proteins can be regulated by USP17 subfamily members. Important direction for future studies should include the isolation and characterization of substrates for USP17. This will help us to understand the cellular roles of USP17.
###end p 32
###begin title 33
Conclusion
###end title 33
###begin p 34
In this study, we report that four novel USP17 subfamily members which encode a deubiquitinating enzyme have been identified and that the overexpression of these proteins leads to cell death. Our study demonstrates that USP17 subfamily members, which regulate apoptosis and cell death of cancerous cells, contain putative hyaluronan and RNA binding motifs. Despite of a decade of research since the discovery of DUB enzymes as an important molecule responsible for regulating protein degradation, much remains to be defined regarding their cellular functions. A better understanding of relation between USP17 subfamily proteins and cell viability will facilitate therapeutic strategies for regulation of cell proliferation.
###end p 34
###begin title 35
Methods
###end title 35
###begin title 36
Specimens and transfection
###end title 36
###begin p 37
###xml 56 58 56 58 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 69 74 <span type="species:ncbi:9606">human</span>
###xml 216 222 <span type="species:ncbi:9913">bovine</span>
Chorionic villi samples used were described previously [36]. Various human cancer cells (HeLa, HEC-1A, NCCIT, and fibrosarcoma cells) were cultured in DMEM (Gibco BRL, Rockville, MD, USA) supplemented with 10% fetal bovine serum (Gibco BRL, Rockville, MD, USA). Transfection was performed with LipofectAMINE reagent (Gibco BRL, Rockville, MD, USA) according to manufacturer's instruction.
###end p 37
###begin title 38
###xml 31 37 31 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17 </italic>
cDNA synthesis and cloning for USP17 subfamily members
###end title 38
###begin p 39
###xml 538 542 538 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DUB </italic>
###xml 747 753 747 753 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17K</italic>
###xml 764 770 764 770 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17L</italic>
###xml 781 787 781 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17M</italic>
###xml 802 809 802 809 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17N </italic>
###xml 839 845 839 845 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17 </italic>
###xml 1018 1020 1018 1020 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 1082 1084 1082 1084 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 353 358 <span type="species:ncbi:9606">human</span>
TRIzol reagent (Gibco BRL, Rockville, MD, USA) was used for total RNA isolation from obtained chorionic villi, HeLa, HEC-1A, NCCIT, and fibrosarcoma cells. cDNA synthesis from obtained total RNA was in accordance with the protocol of SuperScript Preamplification system (Gibco BRL, Rockville, MD, USA). The full-length cDNAs were amplified by RT-PCR in human chorionic villi tissues, HeLa, HEC-1A, NCCIT, and fibrosarcoma cells. Primers (Forward: 5'-CGGGATCCATGGAGGACG-3', Reverse: 5'-GGAATTCCACTGAGATCACT-3') used for isolating putative DUB genes are made on the basis of published sequences [GenBank: ]. Primers used were synthesized commercially and gel-purified prior to use (Bioneer, Daejeon, Korea). To express GST fusion proteins, pGEX-2TK-USP17K, pGEX-2TK-USP17L, pGEX-2TK-USP17M, and pGEX-2TK-USP17N were cloned by inserting each USP17 subfamily member into pGEX-2TK vector (Amersham Life Science, Uppsala, Sweden). BLAST programs on the web site established by the National Center of Biological Information [37] were used for similarity searches in the GenBank, and Pfam [27] program was used for prediction of possible motifs and domains in the protein sequences.
###end p 39
###begin title 40
###xml 29 35 29 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17 </italic>
Site-directed mutagenesis of USP17 subfamily members
###end title 40
###begin p 41
###xml 42 49 42 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17K </italic>
###xml 66 73 66 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17L </italic>
###xml 90 97 90 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17M </italic>
###xml 118 125 118 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17N </italic>
###xml 535 541 526 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17 </italic>
Missense mutation constructs for pGEX-2TK-USP17K (C89S), pGEX-2TK-USP17L (C89S), pGEX-2TK-USP17M (C89S), and pGEX-2TK-USP17N (C89S) were derived from each wild type construct by PCR-based site-directed mutagenesis, using a QuikChangetrade mark Site-Directed Mutagenesis kit (Stratagene, La Jolla, CA, USA) according to manufacturers' instructions. The two primers; forward primer (5'-GGGAAATACCCGCTACGTGAACGCTTC-3') and reverse primer (5'-GAAGCGTTCACGTAGCGGGTATTTCC-3') were used for replacing cysteine with serine at amino acid 89 of USP17 subfamily proteins. Primers used were synthesized commercially and gel-purified prior to use (Bioneer, Daejeon, Korea).
###end p 41
###begin title 42
Northern blot analysis
###end title 42
###begin p 43
###xml 25 27 25 27 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 104 110 104 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17 </italic>
###xml 309 315 309 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17L</italic>
###xml 359 361 359 361 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 130 135 <span type="species:ncbi:9606">human</span>
As described previously [36], Northern blot analysis was carried out to confirm the expression level of USP17 transcripts using a human tissue blot purchased from Clontech. The immobilized nucleic acids were hybridized with radiolabeled DNA probes. Probes used for this study was the 5' 500 bp and 3' 1 kb of USP17L. They were labeled by random primers with [32P]dCTP (Amersham Biosciences, Buckinghamshire, England). Hybridization was performed in a bag containing 5 x SSC, 1 x Denhardt's solution, 100 mug/ml of denatured salmon sperm DNA, 0.1% SDS and 50% formamide at 60degreesC and it was washed in 0.1 x SSC and 0.2% SDS, the membrane was exposed to Kodak X-ray films with an intensifying screen for 24 hours at -70degreesC.
###end p 43
###begin title 44
Deubiquitinating enzyme assays
###end title 44
###begin p 45
###xml 58 59 58 59 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 70 79 70 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 112 118 112 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17K</italic>
###xml 129 136 129 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17K </italic>
###xml 153 159 153 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17L</italic>
###xml 170 177 170 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17L </italic>
###xml 194 200 194 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17M</italic>
###xml 211 218 211 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17M </italic>
###xml 235 241 235 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17N</italic>
###xml 256 263 256 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17N </italic>
###xml 295 303 295 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 399 407 396 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 295 307 <span type="species:ncbi:511693">E. coli BL21</span>
###xml 399 411 <span type="species:ncbi:511693">E. coli BL21</span>
###xml 825 831 <span type="species:ncbi:9986">rabbit</span>
###xml 888 894 <span type="species:ncbi:9986">rabbit</span>
Deubiquitinating enzyme assays were previously described [9]. For the in vitro deubiquitination assay, pGEX-2TK-USP17K, pGEX-2TK-USP17K (C89S), pGEX-2TK-USP17L, pGEX-2TK-USP17L (C89S), pGEX-2TK-USP17M, pGEX-2TK-USP17M (C89S), pGEX-2TK-USP17N, and pGEX-2TK-USP17N (C89S) were co-transformed into E. coli BL21 competent cells (Stratagene, La Jolla, CA, USA) with pACYC184-Ub-beta-gal. Plasmid-bearing E. coli BL21 cells were grown in LB medium and induced with isopropyl-1-thio-beta-D-galactopyranoside (IPTG) for 4 hours at 37degreesC. Cells were harvested and were lysed in cracking buffer (0.01 M phosphate [pH 7.4]. 8 M Urea, 1% SDS, and 1% beta-mercaptoethanol). These whole cell lysates centrifuged for 10 min at 14,000 rpm and the supernatant was loaded onto a 7.5% SDS-PAGE gel. The immunoblotting was performed with a rabbit anti-beta-gal antiserum (ICN, Costa Mesa, CA, USA) or a rabbit anti-GST antiserum (Upstate Biotechnology, Lake Placid, NY, USA).
###end p 45
###begin p 46
###xml 14 20 14 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17 </italic>
###xml 66 74 66 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 114 121 114 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17L </italic>
###xml 135 142 135 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17L </italic>
The effect of USP17 expression on the ubiquitin-proteasome system in vivo was analyzed by transfecting pcDNA3-myc-USP17L or pcDNA3-myc-USP17L (C89S) along with pMT123-HA-ubiquitin into HEC-1A cells. After 24 hours of transfection, cells were harvested and lysed. 40 mug of total proteins was loaded in each lane of a 10% SDS-PAGE for immunoblotting analysis using an anti-HA antibody (Roche Applied Science, Mannheim, Germany). Equal loading was verified by immunoblotting against alpha-myc (Santa Cruz Biotechnology, Santa Cruz, CA, USA).
###end p 46
###begin title 47
Real-time PCR analysis and the Tet-on system
###end title 47
###begin p 48
###xml 37 43 37 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17L</italic>
###xml 557 563 557 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17L</italic>
After the transfection of pcDNA3-myc-USP17L, the expression of caspase 3 as a marker for apoptosis was analyzed by real-time PCR (Opticon2, MJ Research, Ramsey, MN, USA). Product specificity was examined by melting curve analysis and agarose gel electrophoresis after each real-time PCR reaction. To normalize the expression data of the genes, GAPDH was used (Forward primer: 5'-ACTGGTGCTGCCAAGGCTGT-3', Reverse primer: 5'-TCCACCACCCTGTTGCTGTA-3'). Quantification was performed using an internal cDNA standard curve. Fold changes of caspase 3 expression in USP17L-overexpressed cells were calculated relative to the levels in control cells.
###end p 48
###begin p 49
###xml 59 66 59 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17L </italic>
###xml 195 202 195 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17L </italic>
For the long-term (3 weeks) observation and FACS analysis, USP17L was expressed in HeLa cells using the Tet-on system (Gibco BRL, Rockville, MD, USA) by manufacturer's instruction. Expression of USP17L was confirmed by real-time PCR analysis.
###end p 49
###begin title 50
FACS analysis
###end title 50
###begin p 51
###xml 53 60 53 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17L </italic>
###xml 175 176 174 175 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 646 648 632 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
For apoptosis analysis, HeLa-Tet-on cells expressing USP17L were harvested in PBS and resuspended 100 mul of binding buffer (10 mM Hepes/NaOH, pH 7.4, 140 mM NaCl, 2.5 mM CaCl2). 5 mul annexin V-FITC (BD Biosciences, Bedford, MA, USA) and 10 mul propidium iodide (PI, 50 mug/ml, BD Biosciences, Bedford, MA, USA) were added and incubated 15 minutes in the dark. Finally 400 mul of binding buffer was added and analyzed by FACSVantagetrade mark SE system (BD Biosciences, Bedford, MA, USA). Cells in stage of apoptosis were differentiated depending on the location in quadrant (annexin V +, PI -; early stage) and (annexin V +, PI +; late stage) [34].
###end p 51
###begin title 52
Localization study
###end title 52
###begin p 53
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17L </italic>
###xml 11 18 11 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17N </italic>
###xml 232 239 232 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17L </italic>
###xml 254 261 254 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17N </italic>
###xml 609 616 608 615 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17L </italic>
###xml 630 636 629 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17N</italic>
USP17L and USP17N were subcloned into pEGFP-C1 and pDsRed-C1 (Clontech, Palo Alto, CA, USA), respectively, and transfected into HeLa cells using ExGen500 (Fermentas, Hanover, MD, USA). After 48 hours, the localization of GFP-tagged USP17L and RFP-tagged USP17N was observed using a confocal microscopy (Radiance 2100 2Q, Bio-Rad, Hercules, CA, USA). In order to observe the morphology of nuclei for HeLa cells, DAPI staining was performed. After the fixation, 5 mul of DAPI staining solution (Roche Applied Science, Mannheim, Germany) was added in wells containing HeLa cells, which express either GFP-tagged USP17L or RFP-tagged USP17N. Stained cells were observed using Nikon Eclipse E600 microscopy.
###end p 53
###begin title 54
Hyaluronan- and RNA-binding assays
###end title 54
###begin p 55
###xml 40 42 40 42 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 65 72 64 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17L </italic>
###xml 86 93 85 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17N </italic>
###xml 132 134 131 133 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6 </sup>
These assays were previously described [29]. 9 mug of pcDNA3-myc-USP17L or pcDNA3-myc-USP17N was transiently transfected into 1 x 106 HeLa cells in 100Phi dish by ExGen500 transfection reagent (Fermentas, Hanover, MD, USA). The supernatant from lysates was divided into 100 mul aliquots in Eppendorf tube and incubated at room temperature with 50 mug of hyaluronan (H5388, Sigma, St. Louis, MO, USA). For RNA binding assay, this procedure was repeated with using total RNA of HeLa cells instead of hyaluronan.
###end p 55
###begin title 56
Abbreviations
###end title 56
###begin p 57
###xml 200 201 200 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
CPC, cetylpyridinium chloride; DUB, deubiquitinating enzyme; E1, ubiquitin-activating enzyme; E2, ubiquitin-conjugating enzyme; E3, ubiquitin ligase; ECL, enhanced chemiluminescence; GST, glutathione S-transferase; HA, hemagglutinin; IHABPS, intracellular hyaluronan binding proteins; IP, immunoprecipitation; JAMM, Jab1/Pab1/MPN-domain-containing metallo-enzyme; OTU, otu-domain ubiquitin aldehyde-binding protein; PCR, polymerase chain reaction; PI, propidium iodide; RHAMM, receptor form hyaluronan-mediated motility; SDS-PAGE; sodium dodecyl sulfate-polyacrylamide gel electrophoresis; Ub, ubiquitin; UBP, ubiquitin specific processing protease; UCH, ubiquitin C-terminal hydrolase.
###end p 57
###begin title 58
Authors' contributions
###end title 58
###begin p 59
JMS participated in molecular cloning, sequence alignment and immunoassay. KJY carried out the molecular cloning and binding assays. MSK carried out the immunoassay and microscopic assay. DK carried out FACS analysis. KHB conceived of the study, participated in its design and coordination and helped to draft the manuscript. All authors read and approved the final manuscript.
###end p 59
###begin title 60
Supplementary Material
###end title 60
###begin title 61
Additional File 1
###end title 61
###begin p 62
Alignment of amino acid sequences for USP17, DUB-3, and novel USP17 subfamily members (USP17K to USP17N) (GenBank accession numbers: , , , , , and , respectively) using MegAlign software (Clustal method) from DNA Star (LaserGene). Different amino acids are blocked.
###end p 62
###begin p 63
Click here for file
###end p 63
###begin title 64
Acknowledgements
###end title 64
###begin p 65
We wish to thank the members of the Fertility Medical Center and Cell and Gene Therapy Research Institute at Pochon CHA University and CHA General Hospital. We thank Dr. Bryan P. Toole for his advice on hyaluronan binding assay. We also would like to thank Dr. Natalie Beaty at NIH for her critical comments on the manuscript and Sung-Hwan Moon for his technical assistance for confocal microscope. This work was supported by Korea Research Foundation Grant funded by Korea Government (MOEHRD, Basic Research Promotion Fund) (KRF-2005-015-C00284).
###end p 65
###begin article-title 66
Cytokine-regulated protein degradation by the ubiquitination system
###end article-title 66
###begin article-title 67
ubiquitin-proteasome pathway: on protein death and cell life
###end article-title 67
###begin article-title 68
###xml 20 31 20 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 20 30 <span type="species:ncbi:7227">Drosophila</span>
The function of the Drosophila Fat facets deubiquitinating enzyme in limiting photoreceptor cell number is intimately associated with endocytosis
###end article-title 68
###begin article-title 69
###xml 61 66 <span type="species:ncbi:10090">mouse</span>
FAM deubiquitinating enzyme is essential for preimplantation mouse embryo development
###end article-title 69
###begin article-title 70
Deubiquitinating enzymes: a new class of biological regulators
###end article-title 70
###begin article-title 71
UBP41 is a proapoptotic ubiquitin-specific protease
###end article-title 71
###begin article-title 72
A novel ubiquitination factor, E4, is involved in multiubiquitin chain assembly
###end article-title 72
###begin article-title 73
Mechanism and function of deubiquitinating ezymes
###end article-title 73
###begin article-title 74
DUB-1A, a novel subfamily member of deubiquitinating enzyme, is polyubiquitinated and cytokine inducible in B-lymphocytes
###end article-title 74
###begin article-title 75
Role of predicted metalloprotease motif of Jab1/Csn5 in cleavage of Nedd8 from Cul1
###end article-title 75
###begin article-title 76
Role of Rpn11 metalloprotease in deubiquitination and degradation by the 26S proteasome
###end article-title 76
###begin article-title 77
A novel type of deubiquitinating enzyme
###end article-title 77
###begin article-title 78
Intracellular hyaluronan: a new frontier for inflammation?
###end article-title 78
###begin article-title 79
###xml 27 35 27 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
Inhibition of tumor growth in vivo by hyaluronan oligomers
###end article-title 79
###begin article-title 80
Differential involvement of the hyaluronan (HA) receptors CD44 and receptor for HA-mediated motility in endothelial cell function and angiogenesis
###end article-title 80
###begin article-title 81
Rapid hyaluronan uptake is associated with enhanced motility: implications for an intracellular mode of action
###end article-title 81
###begin article-title 82
Molecular characterization of a novel intracellular hyaluronan-binding protein
###end article-title 82
###begin article-title 83
Soluble hyaluronan receptor RHAMM induces mitotic arrest by suppressing Cdc2 and cyclin B1 expression
###end article-title 83
###begin article-title 84
RHAMM is a centrosomal protein that interacts with dynein and maintains spindle pole stability
###end article-title 84
###begin article-title 85
The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence
###end article-title 85
###begin article-title 86
DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation
###end article-title 86
###begin article-title 87
###xml 56 61 <span type="species:ncbi:10090">mouse</span>
Molecular cloning and complete cDNA sequence of UBH1 in mouse testis
###end article-title 87
###begin article-title 88
###xml 35 40 <span type="species:ncbi:9606">human</span>
Unstable transmission of the RS447 human megasatellite tandem repetitive sequence that contains the USP17 deubiquitinating enzyme gene
###end article-title 88
###begin article-title 89
Deubiquitinating enzyme USP36 contains the PEST motif and is polyubiquitinated
###end article-title 89
###begin article-title 90
DUB-1, a deubiquitinating enzymes with growth-suppressing activity
###end article-title 90
###begin article-title 91
DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes
###end article-title 91
###begin article-title 92
Pfam
###end article-title 92
###begin article-title 93
Identification of a common hyaluronan binding motif in the hyaluronan binding proteins RHAMM, CD44 and link protein
###end article-title 93
###begin article-title 94
Variant exons v6 and v7 together expand the repertoire of glycosaminoglycans bound by CD44
###end article-title 94
###begin article-title 95
Identification and cDNA cloning of a novel RNA-binding protein that interacts with the cyclic nucleotide-responsive sequence in the type-1 plasminogen activator inhibitor mRNA
###end article-title 95
###begin article-title 96
Intracellular localization of hyaluronan in proliferating cells
###end article-title 96
###begin article-title 97
Hyaluronan: from extracellular glue to pericellular cue
###end article-title 97
###begin article-title 98
Hyaluronan-cell interactions in cancer and vascular disease
###end article-title 98
###begin article-title 99
Comparative measurement of spontaneous apoptosis in pediatric acute leukaemia by different techniques
###end article-title 99
###begin article-title 100
Formation of hyaluronan- and versican-rich pericellular matrix is required for proliferation and migration of vascular smooth muscle cells
###end article-title 100
###begin article-title 101
###xml 113 121 <span type="species:ncbi:9606">patients</span>
Expression of angiogenesis- and apoptosis-related genes in chorionic villi derived from recurrent pregnancy loss patients
###end article-title 101
###begin article-title 102
National Center of Biological Information (NCBI)
###end article-title 102
###begin title 103
Figures and Tables
###end title 103
###begin p 104
###xml 105 110 <span type="species:ncbi:9606">human</span>
###xml 118 123 <span type="species:ncbi:10090">mouse</span>
Conserved domains of USP17 subfamily members were compared with other deubiquitinating enzymes including human USP36, mouse DUB-1, and DUB-2. These domains are critical for the function of deubiquitinating enzymes.
###end p 104
###begin p 105
Phylogenetic tree assignments of USP17 subfamily members. Sequence names and GenBank accession numbers are as follows: USP17, ; DUB-3, ; USP17A, ; USP17B, ; USP17C, ; USP17D, ; USP17F, ; USP17G, ; USP17H, ; USP17I, ; USP17J, ; USP17K, ; USP17L, ; USP17M, , USP17N, . Novel members of USP17 subfamily are underlined. USP17E sequence identified previously [20] could not be located with the reported GenBank accession number ().
###end p 105
###begin p 106
###xml 248 249 248 249 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
Schematic diagram of structural features for USP17 subfamily members. The domains required for deubiquitinating activity (Cys, Asp (I) His, Asp/Asn (II)) are located at the 5' end and middle of enzymes. Two potential hyaluronan binding motifs R/K(X7)R/K are located at amino acids 401 to 410, and 445 to 453.
###end p 106
###begin p 107
###xml 27 33 27 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17 </italic>
###xml 276 283 276 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17L </italic>
###xml 327 333 327 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17 </italic>
###xml 468 474 465 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17 </italic>
###xml 54 59 <span type="species:ncbi:9606">human</span>
###xml 91 96 <span type="species:ncbi:9606">human</span>
###xml 224 229 <span type="species:ncbi:9606">human</span>
###xml 404 409 <span type="species:ncbi:9606">human</span>
Northern blot analysis for USP17 subfamily members in human tissues and RT-PCR analysis in human tumor cell lines. (A) Northern blot analysis was carried out to investigate the expression level of USP17 subfamily members in human tissues. The 5' 500 bp- and 3' 1 kb-probes of USP17L were used. The multiple transcript sizes of USP17 mRNA including 1.6 kb were detected. The same blot was probed with the human beta-actin as a loading control. (B) Global expression of USP17 subfamily members in various cancer cell lines.
###end p 107
###begin p 108
###xml 66 75 66 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro </italic>
###xml 270 277 267 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17K </italic>
###xml 296 303 293 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17K </italic>
###xml 329 336 326 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17L </italic>
###xml 355 362 352 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17L </italic>
###xml 388 395 385 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17M </italic>
###xml 414 421 411 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17M </italic>
###xml 447 454 444 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17N </italic>
###xml 477 484 474 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17N </italic>
Deubiquitinating enzyme assays for novel USP17 subfamily members. In vitro deubiquitinating enzyme activity for USP17K, USP17L, USP17M, and USP17N. Immunoblotting analysis was performed with anti-beta-gal antiserum. Coexpressed plasmids were pGEX-2TK (lane 1), pGEX-2TK-USP17K (lane 2), pGEX-2TK-USP17K (C89S) (lane 3), pGEX-2TK-USP17L (lane 4), pGEX-2TK-USP17L (C89S) (lane 5), pGEX-2TK-USP17M (lane 6), pGEX-2TK-USP17M (C89S) (lane 7), pGEX-2TK-USP17N (lane 8), and pGEX-2TK-USP17N (C89S) (lane 9). All of normal USP17 subfamily members cleaved the linkage between ubiquitin and beta-galactosidase.
###end p 108
###begin p 109
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vivo </italic>
###xml 93 103 93 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ubiquitin </italic>
###xml 168 171 168 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myc</italic>
###xml 172 179 172 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17L </italic>
###xml 190 193 190 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myc</italic>
###xml 194 201 194 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17L </italic>
###xml 303 306 303 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myc</italic>
###xml 307 313 307 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17L</italic>
###xml 350 353 350 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myc</italic>
###xml 354 361 354 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17L </italic>
In vivo deubiquitinating enzyme assay for the novel USP17 subfamily member. HA-tagged pMT123-ubiquitin was transiently expressed in HEC-1A cells with or without pcDNA3-myc-USP17L and pcDNA3-myc-USP17L (C89S). The expression levels of polyubiquitinated proteins were decreased in cells expressing pcDNA3-myc-USP17L, but not in cells expressing pcDNA3-myc-USP17L (C89S).
###end p 109
###begin p 110
###xml 221 228 221 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17L </italic>
###xml 242 249 242 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17N </italic>
###xml 499 505 499 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17 </italic>
###xml 648 655 648 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17L </italic>
###xml 669 676 669 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17N </italic>
Hyaluronan/RNA-binding assays. To confirm the interaction of USP17 subfamily proteins with either hyaluronan or RNA, CPC precipitation assay was performed. Cell lysate aliquots from HeLa cells transfected with myc-tagged USP17L or myc-tagged USP17N construct were incubated with hyaluronan or RNA and subjected to CPC precipitation. (A) Coprecipitated proteins were subjected to Western blot analysis with an antibody against the myc tag. CPC precipitation without the addition of CPC or myc-tagged USP17 construct was used as negative controls (lanes 1-3). Without the addition of CPC, the whole cell lysate from cells transfected with myc-tagged USP17L or myc-tagged USP17N was used as a positive control (lane 7). (B) For RNA binding assay, total RNA of HeLa cells instead of hyaluronan were added.
###end p 110
###begin p 111
The localization of USP17L and USP17N in HeLa cells. pEGFP-C1 vector (A) or pDsRed-C1 vector (B) transfected into HeLa cells was used as controls. In addition, GFP-tagged USP17L (C) or RFP-tagged USP17N (D) transfected into HeLa cells was used as controls. (E-G) HeLa cells co-transfected with GFP-tagged USP17L and RFP-tagged USP17N are shown with lower magnification (E-G) and with higher magnification (H-J). GFP-tagged USP17L proteins are highly condensed at the nucleoli in the nucleus (H: marked by arrows). RFP-tagged USP17N proteins are present both in the nucleus and cytoplasm (I: marked by arrows). GFP-tagged USP17L and RFP-tagged USP17N were combined in HeLa cells (G and J).
###end p 111
###begin p 112
###xml 14 20 14 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17 </italic>
###xml 64 70 64 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17L</italic>
###xml 122 129 122 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17L </italic>
###xml 139 146 139 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17N </italic>
The effect of USP17 expression in HeLa cells. Overexpression of USP17L-induced apoptosis of cervical cancer cells. Either USP17L (C89S) or USP17N did not induce apoptosis.
###end p 112
###begin p 113
###xml 14 20 14 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17 </italic>
###xml 66 76 66 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase 3 </italic>
###xml 117 127 117 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase 3 </italic>
###xml 198 208 198 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caspase 3 </italic>
###xml 245 251 245 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17L</italic>
###xml 253 260 253 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17L </italic>
###xml 270 277 270 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17N </italic>
The effect of USP17 expression in HeLa cells. Relative amounts of caspase 3 produced by real-time PCR. The amount of caspase 3 DNA in the control group was calibrated as 100 and relative amounts of caspase 3 DNA in cells transfected with either USP17L, USP17L (C89S) or USP17N were determined.
###end p 113
###begin p 114
###xml 36 42 36 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17L</italic>
###xml 44 51 44 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17L </italic>
###xml 62 69 62 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">USP17N </italic>
(A) FACS analysis. Cells expressing USP17L, USP17L (C89S), or USP17N were harvested 1 week apart for 3 weeks, fixed with ethanol, and stained with annexin V and PI. (B) The graph shows the ratio of cells in early (annexin V +, PI -) and late (annexin V +, PI +) stage apoptosis. The ratio of HeLa cells was calibrated as 100%.
###end p 114
###begin p 115
Percent amino acid identity among USP17 subfamily and DUB subfamily members.
###end p 115

